HC Wainwright Has Bearish Forecast for CLMT Q1 Earnings

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Free Report) - Analysts at HC Wainwright decreased their Q1 2025 earnings estimates for shares of Calumet Specialty Products Partners in a research note issued to investors on Monday, March 3rd. HC Wainwright analyst A. Dayal now forecasts that the oil and gas company will post earnings of ($0.43) per share for the quarter, down from their prior estimate of ($0.34). HC Wainwright currently has a "Buy" rating and a $33.00 price target on the stock. The consensus estimate for Calumet Specialty Products Partners' current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet Specialty Products Partners' Q2 2025 earnings at ($0.34) EPS, Q3 2025 earnings at ($0.18) EPS, Q4 2025 earnings at ($0.08) EPS, FY2025 earnings at ($1.04) EPS, FY2026 earnings at $0.14 EPS, FY2027 earnings at $1.11 EPS, FY2028 earnings at $2.06 EPS and FY2029 earnings at $2.58 EPS.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to analysts' expectations of $921.76 million. The firm's revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.59) EPS.

Remove Ads

Several other equities research analysts have also recently issued reports on the stock. Wells Fargo & Company cut their price objective on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday. UBS Group lowered shares of Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and lowered their price objective for the company from $20.50 to $15.00 in a research note on Tuesday, February 4th. TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their target price for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. Finally, StockNews.com raised shares of Calumet Specialty Products Partners to a "sell" rating in a report on Monday, November 18th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $21.40.

Calumet Specialty Products Partners Trading Down 3.9 %

NASDAQ:CLMT traded down $0.48 during trading hours on Wednesday, reaching $11.97. 830,805 shares of the company were exchanged, compared to its average volume of 1,442,439. The stock's 50-day moving average is $17.33 and its 200-day moving average is $19.09. The firm has a market cap of $1.03 billion, a PE ratio of -4.34 and a beta of 1.88. Calumet Specialty Products Partners has a twelve month low of $9.97 and a twelve month high of $25.29.

Insider Transactions at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the business's stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total value of $810,982.62. Following the sale, the director now directly owns 1,184,589 shares in the company, valued at approximately $25,373,896.38. The trade was a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO David Lunin purchased 2,500 shares of the company's stock in a transaction on Tuesday, March 4th. The stock was acquired at an average price of $13.05 per share, for a total transaction of $32,625.00. Following the completion of the transaction, the chief financial officer now owns 2,500 shares of the company's stock, valued at $32,625. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 2.91% of the company's stock.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.